Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer

Carcinogenesis

Volumn 29, Issue 6, 2008, Pages 1184-1191

  Suzuki, Hideo ^a   Morris, Jeffrey S ^a   Li, Yanan ^a   Doll, Mark A ^c   Hein, David W ^c   Liu, Jun ^a   Jiao, Li ^b   Hassan, Manal M ^a   Day, Rea S ^d   Bondy, Melissa L ^a   Abbruzzese, James L ^a   Li, Donghui ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ACYLTRANSFERASE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450 1A2; HETEROCYCLIC AMINE; MUTAGENIC AGENT; NITROSO DERIVATIVE; SULFOTRANSFERASE 1A1;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPOTHESIS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PANCREAS ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICOKINETICS;

ARYLAMINE N-ACETYLTRANSFERASE; ARYLSULFOTRANSFERASE; CARCINOGENS; CARCINOMA, PANCREATIC DUCTAL; CYTOCHROME P-450 CYP1A2; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MUTAGENS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 46949090331     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn085     Document Type: Article

References (59)

1. American Cancer Society. (2007) Cancer Figures and Facts 2007. Atlanta.
2. Ahlgren,J.D. (1996) Epidemiology and risk factors in pancreatic cancer. Semin. Oncol., 23, 241-250.
3. Brownson,R.C. et al. (2002) Epidemiology of environmental tobacco smoke exposure. Oncogene, 21, 7341-7348.
4. Lang,N.P. et al. (1991) Aromatic and heterocyclic amine metabolism and phenotyping in humans. Prog. Clin. Biol. Res., 372, 33-47.
5. Li,D. et al. (2006) Polymorphisms of cytochrome P4501A2 and N acetyl-transferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis, 27, 103-111.
6. Jiao,L. et al. (2007) Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 16, 2379-2386.
7. Duell,E.J. et al. (2002) A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J. Natl Cancer Inst., 94, 297-306.
8. Anderson,K. et al. (1996) Pancreatic cancer. In Schottenfeld,D., Fraumeni, J.F.Jr. (eds.) Cancer Epidemiology and Prevention. Oxford University Press, New York, NY, pp. 725-771.
9. Ji,B.T. et al. (1995) Dietary factors and the risk of pancreatic cancer: A case-control study in Shanghai, China. Cancer Epidemiol. Biomarkers Prev., 4, 885-893.
10. Ghadirian,P. et al. (1995) Food habits and pancreatic cancer: A case-control study of the Francophone community in Montreal, Canada. Cancer Epidemiol. Biomarkers Prev., 4, 895-899.
11. Knekt,P. et al. (1994) Intake of fried meat and risk of cancer: A follow-up study in Finland. Int. J. Cancer, 59, 756-760.
12. Skog,K. (1993) Cooking procedures and food mutagens: A literature review. Food Chem. Toxicol., 31, 655-675.
13. Sugimura,T. et al. (1994) Heterocyclic amines in cooked foods: candidates for causation of common cancers. J. Natl Cancer Inst., 86, 2-4.
14. Risch,H.A. (2003) Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J. Natl Cancer Inst., 95, 948-960.
15. Sugio,K. et al. (1996) High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters. Carcinogenesis, 17, 303-309.
16. IARC. (1993) Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines, and mycotoxins. In IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans Lyon, IARC, 571.
17. Sugimura,T. et al. (1991) Heterocyclic amines: New mutagens and carcinogens in cooked foods. Adv. Exp. Med. Biol., 283, 569-78.
18. Yoshimoto,M. et al. (1999) Carcinogenicity of heterocyclic amines for the pancreatic duct epithelium in hamsters. Cancer Lett., 143, 235-239.
19. Tamano,S. et al. (1994) Carcinogenicity of a mutagenic compound from food, 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAaC), in male F344 rats. Carcinogenesis, 15, 2009-2015.
20. Howard,J.W. et al. (1980) Analytical methodology and reported findings of polycyclic aromatic hydrocarbons in foods. J. Assoc. Off. Anal. Chem., 63, 1077-1104.
21. Triolo,A.J. et al. (1977) Induction of aryl hydrocarbon hydroxylase and forestomach tumors by benzo(a)pyrene. Cancer Res., 37, 3018-3021.
22. Anderson,K.E. et al. (2005) Dietary intake of heterocyclicamines and benzo(a)pyrene: Associations with pancreatic cancer. Cancer Epidemiol. Biomarkers Prev., 14, 2261-2265.
23. Li,D. et al. (2007) Dietary mutagen exposure and risk of pancreatic cancer. Cancer Epidemiol. Biomarkers Prev., 16, 655-661.
24. Eaton,D.L. et al. (1995) Role of cytochrome P4501A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity. Pharmacogenetics, 5, 259-274.
25. Glatt,H.R. (1997) Sulfation and sulfotransferases, IV. Bioactivation of mutagens via sulfation. FASEB J., 11, 314-321.
26. Lewis,A.J. et al. (1998) Bioactivation of the cooked food mutagen N-hydroxy- 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. Carcinogenesis, 19, 2049-2053.
27. Miller,J.A. (1994) Sulfonation in chemical carcinogenesis: History and present status. Chem. Biol. Interact., 92, 329-341.
28. Butler,M.A. et al. (1989) Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl Acad. Sci. USA, 86, 7696-7700.
29. Kato,R. et al. (1987) Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Jpn. J. Cancer Res., 78, 297-311.
30. Sachse,C. et al. (2003) Colorectal Cancer Study Group. Polymorphisms in the cytochrome P450 CYPIA2 gene (CYPIA2) in colorectal cancer patients and controls: Allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br. J. Clin. Pharmacol., 55, 68-76.
31. Anderson,K.E. et al. (1997) Metabolic activation of aromatic amines by human pancreas. Carcinogenesis, 18, 1085-1092.
32. Hickman,D. et al. (1998) Expression of arylamine N acetyltransferase in human intestine. Gut, 42, 402-409.
33. Husain,A. et al. (2007) Identification of N acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab. Dispos., 35 721-727.
34. Hein,D.W. (2002) Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat. Res., 30, 506-507, 65-77.
35. Hein,D.W. et al. (2000) Update on consensus N acetyltransferase gene nomenclature. Pharmacogenetics, 10 291-292.
36. Hirvonen,A. (1999) Polymorphic NATs and cancer predisposition. IARC Sci. Publ., 251-270.
37. Hein,D.W. et al. (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev., 9, 29-42.
38. Hengstler,J.G. et al. (1998) Polymorphisms of N acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility. Recent Results Cancer Res., 154, 47-85.
39. Engelke,C.E. et al. (2000) Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. Pharmacogenetics, 10, 163-169.
40. Raftogianis,R.B. et al. (1997) Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype. Biochem. Biophys. Res. Commun., 239, 298-304.
41. Steiner,M. et al. (2000) Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer lack of association. Arch. Toxicol. 74, 222-225.
42. Sachse,C. et al. (2002) Colorectal Cancer Study Group. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis, 23, 1839-1849.
43. Wang,Y. et al. (2002) Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: A case-control analysis. Lung Cancer, 35, 137-142.
44. Saintot,M. et al. (2003) Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o methyltransferase and tobacco exposure in breast cancer risk. Int. J. Cancer, 107, 652-657.
45. Zheng,L. et al. (2003) Sulfotransferase 1A1 (SULT1A1) Polymorphism and bladder cancer risk: A case-control study. Cancer Lett., 202, 61-69.
46. Wu,M.T. et al. (2003) SULT1A1 polymorphism and esophageal cancer in males. Int. J. Cancer, 103, 101-104.
47. Knize,M.G. et al. (1999) Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatic hydrocarbon mutagens/ carcinogens. Adv. Exp. Med. Biol., 459, 179-193.
48. Livak,K.J. (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet. Anal., 14, 143-149.
49. Doll,M.A. et al. (2001) Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. Anal. Biochem., 288, 106-108.
50. Doll,M.A. et al. (2002) Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N acetyltransferase-1. Anal. Biochem., 301, 328-332.
51. Ruczinski,I. et al. (2003) Logic regression. J. Comput. Graph. Stat., 12, 475-511.
52. Muscat,J.E. et al. (1997) Smoking and pancreatic cancer in men and women. Cancer Epidemiol. Biomarkers Prev., 6, 15-19.
53. Nilsen,T.I. et al. (2000) A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trondelag, Norway. Cancer Causes Control, 11, 645-652.
54. Stolzenberg-Solomon,R.Z. et al. (2007) Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol. Biomarkers Prev., 16, 2664-2675.
55. Estrada-Rodgers,L. et al. (1998) Characterization of a hormone response element in the mouse N-acetyltransferase 2 (Nat2) promoter. Gene Expr., 7, 13-24.
56. Coughlin,S.S. et al. (2000) Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control, 11, 915-923.
57. Silverman,D.T. et al. (1998) Dietary and nutritional factors and pancreatic cancer: A case-control study based on direct interviews. J. Natl Cancer Inst., 90, 1710-1719.
58. Larsson,S.C. et al. (2006) Meat, fish, poultry and egg consumption in relation to risk of pancreatic cancer: A prospective study. Int. J. Cancer, 118, 2866-2870.
59. Hein,D.W. et al. (2000) Pharmacogenetics of the arylamine N acetyltransferases: A symposium in honor of Wendell W. Weber. Drug Metab. Dispos., 28, 1425-1432.